{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:36:05Z","timestamp":1787999765873,"version":"build-2784847793"},"reference-count":12,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,3,31]],"date-time":"2006-03-31T00:00:00Z","timestamp":1143763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Pseudo\u2010von Willebrand disease (p\u2010VWD) and type 2B von Willebrand disease (VWD) have similar phenotypic parameters and clinical symptoms, but different aetiologies. Fourteen individuals from five families with a historical diagnosis of type 2B VWD but with no mutation in the von Willebrand factor gene were re\u2010investigated for the possibility of p\u2010VWD, using platelet aggregation in the presence of cryoprecipitate. p\u2010VWD was confirmed by targeted DNA sequencing of the glycoprotein Ib<jats:italic>\u03b1<\/jats:italic> gene, identifying a heterozygous Glycine 233 Valine substitution. This study suggests that p\u2010VWD may be under diagnosed, and that platelet aggregation in the presence of cryoprecipitate is useful in differentiating this disorder from type 2B VWD.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2006.06078.x","type":"journal-article","created":{"date-parts":[[2006,3,31]],"date-time":"2006-03-31T14:50:58Z","timestamp":1143816658000},"page":"664-666","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Distinguishing between type 2B and pseudo\u2010von Willebrand disease and its clinical importance"],"prefix":"10.1111","volume":"133","author":[{"given":"Mohammad S.","family":"Enayat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Guilliatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan T.","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.H.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,5,16]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.3.674"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00369.x"},{"key":"e_1_2_5_4_1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1055\/s-0038-1650385","article-title":"Platelet\u2010type von Willebrand disease","volume":"75","author":"Miller J.L.","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111112"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.11.4761"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2942"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.3.555.555"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198005083021902"},{"key":"e_1_2_5_10_1","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1182\/blood.V64.6.1254.1254","article-title":"Further characterization of platelet\u2010type von Willebrand's disease in Japan","volume":"64","author":"Takahashi H","year":"1984","journal-title":"Blood"},{"key":"e_1_2_5_11_1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood.V85.3.727.bloodjournal853727","article-title":"Substitution of Val for Met at residue 239 of platelet glycoprotein Ib\u03b1 in Japanese patients with platelet\u2010type von Willebrand disease","volume":"85","author":"Takahashi H.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198202113060603"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1994.1241"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2006.06078.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2006.06078.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T18:06:01Z","timestamp":1697393161000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2006.06078.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,16]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1111\/j.1365-2141.2006.06078.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06078.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,16]]},"assertion":[{"value":"2006-05-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}